In vitro human osteoblast and extracellular matrix changes after transforming growth factor beta 1 treatment

Pathology

Volumn 37, Issue 5, 2005, Pages 347-354

  Stabellini, G ^a,f   Vertemati, M ^a   Locci, P ^b   Calvitti, M ^b   Minola, E ^c   Calastrini, C ^d   Pellati, A ^d   Carinci, F ^e   Marinucci, L ^b   Lilli, C ^b   Baroni, T ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

^e S ANNA HOSPITAL   (Italy)

^f Human Morphology Department   (Italy)

Author keywords

Extracellular bone matrix; Human osteoblast; Uraemic patients; Uremic patients

Indexed keywords

ALKALINE PHOSPHATASE; BETA GLUCURONIDASE; COLLAGEN; GLUCOSAMINIDASE; GLYCOSAMINOGLYCAN; N ACETYL BETA GLUCOSAMINIDASE; OSTEOCALCIN; PROLINE; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BONE DEFECT; CELL PROLIFERATION; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCAN METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MINERALIZATION; OSSIFICATION; OSTEOBLAST; PROTEIN SECRETION; UREMIA;

EID: 27144560211     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020500254487     Document Type: Article

References (35)

1. Canalis E, McCarthy TL, Centrella M. Growth factors and cytokines in bone cell metabolism. Ann Rev Med 1991; 42: 17-24.
2. Reyes-Botella C, Vallecillo-Capilla MF, Ruiz C. Effect of different growth factors on human cultured osteoblast-like cells. Cell Physiol Biochem 2002; 12: 353-8.
3. Zhang H, Ahmad M, Gronowicz G. Effects of transforming growth factor-beta 1 (TGF-beta 1) on in vitro mineralization of human osteoblasts on implant materials. Biomaterials 2003; 24: 2013-20.
4. Duarte MEI, Carvalho EF, Cruz EAS, Lucerna SBG, Andress DL. Cytokine accumulation in osteitis fibrosa of renal osteodystrophy. Braz J Med Biol Res 2002; 35: 25-9.
5. Herbelin A, Urena P, Nguyen AT, Zingraff J, Descamps-Latscha B. Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int 1991; 39: 954-60.
6. Pertosa G, Grandaliano G, Gesualdo L, Schena FP. Clinical relevance of cytokine production in hemodialysis. Kidney Int Suppl 2000; 76: S104-11.
7. Bodo M, Venti G, Pezzetti F, et al. Interleukin-1 alpha: regulation of cellular proliferation and collagen synthesis in cultured human osteoblasts-like cells. Cell Mol Biol 1992; 38: 679-86.
8. Reilly JT. Pathogenesis of idiopathic myelofibrosis: Role of growth factors. J Clin Pathol 1992; 45: 461-4.
9. Richiert DM, Ireland ME. Matrix metalloproteinase secretion is stimulated by TGF-beta in cultured lens epithelial cells. Curr Eye Res 1999; 19: 269-75.
10. Evangelisti R, Valeno V, Bosi G, et al. A contribution to the regulation of proteoglycan production: modulation by TGF alpha, TGF beta and IL-1 of glycosaminoglycan biosynthesis on beta-D-xyloside in chick embryo fibroblasts. Connect Tissue Res 1998; 37: 77-85.
11. Locci P, Marinucci L, Lilli C, Martinese D, Becchetti E. Transforming growth factor beta 1-hyaluronic acid interaction. Cell Tissue Res 1995; 281: 317-24.
12. Romberg RW, Werness PG, Rigg BL, Mann KG. Inhibition of hydroxyapatite crystal growth by bone-specific and other calcium-binding proteins. Biochemistry 1986; 25: 1176-80.
13. Lian JB, Dunn K, Key L Jr. In vitro degradation of bone particles by human monocytes is decreased with the depletion of the vitamin K-dependent bone protein from the matrix. Endocrinology 1986; 118: 1636-42.
14. Acott PD, Crocker JFS, Wong JA. Decreased bone mineral density in the pediatric renal transplant population. Ped Transplant 2003; 7: 358-63.
15. Humes HD, Weitzel WF, Fissell WH. Renal cell therapy in the treatment of patients with acute and chronic renal failure. Blood Purif 2004; 22: 60-72.
16. Maurizi M, Binaglia L, Donti E, Ottaviani F, Paludetti G, Venti Donti G. Morphological and functional characteristics of human temporal-bone cell cultures. Cell Tissue Res 1983; 229: 505-13.
17. Bodo M, Venti G, Baroni T, Pezzetti F, Mariggiò MA, Maurizi M. Morphology, growth and collagen production in otosclerotic bone cells treated with interleukin 1-alpha. Med Sci Res 1992; 20: 577-80.
18. Webster DF, Harvey W. A quantitative assay for collagen synthesis in microwell fibroblast cultures. Anal Biochem 1979; 96: 220-24.
19. Gillies RJ, Didier N, Denton M. Determination of cell number in monolayer cultures. Anal Biochem 1986; 159: 109-13.
20. Patterson MK. Measurement of growth and viability of cells in culture. In: Jacob WB, Pastan IH, editors. Methods in Enzymology. New York: Academic Press, 1979; 141-5.
21. Orlacchio A, Maffei C, Emiliani C, Rambotti P, Davis S. A distinct β-exosaminidase isoenzyme separated from human leukemic lymphocytes and myelocytes. Biochem Biophys Res Comm 1984; 122: 966-73.
22. Bradford MM. A rapid and sensitive methods for the quantitation of microgram of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
23. Ibbotson KJ, Harrod J, Gowen M, et al. Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro. Proc Natl Acad Sci USA 1986; 83: 2228-32.
24. Ballanti P, Coen G, Mazzaferro S, et al. Histomorphometric assessment of bone turnover in uraemic patients: comparison between activation frequency and bone formation rate. Histopathology 2001; 38: 571-83.
25. Jarava C, Armas JR, Palma A. Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodelling markers. Nefrologia 2000; 20: 363-72.
26. Bushinsky DA, Favus MJ, Schneider AB, Sen PK, Sherwood LM, Coe FL. The effects of metabolic acidosis on PTH and 1,25(OH)2D3 response to low-calcium diet. Am J Physiol 1982; 281: F1058-66.
27. Krieger NC, Bushinsky DA, Frick KK. Cellular mechanisms of bone resorption induced by metabolic acidosis. Semin Dial 2003; 16: 463-6.
28. Spinella-Jaegle S, Roman-Roman S, Faucheu C, et al. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta 1 on osteoblast differentiation. Bone 2001; 29: 323-30.
29. Roelen BAJ, ten Duke P. Controlling mesenchymal stem cell differentiation by TGFβ family members. J Orthop Sci 2003; 8: 740-8.
30. 1 in osteoclast differentiation and survival. J Cell Science 2000; 113: 2445-53.
31. Logan A, Smith C, Becks GP, Gonzales AM, Phillips ID, Hill DJ. Enhanced expression of transforming growth factor-beta 1 during thyroid hyperplasia in rats. J Endocrinol 1994; 141: 45-57.
32. Khosla S, Oursler MJ, Schroeder MJ, Eberhardt NL. Transforming growth factor-beta 1 induces growth inhibition of human medullary thyroid carcinoma cell line despite an increase in steady state c-myc messenger ribonucleic acid levels. Endocrinology 1994; 135: 1887-93.
33. 1. J Cell Biochem 2001; 83: 320-32.
34. Bedani PL, Orzincolo C, Scutellari PN, Gilli P. Imaging dell'apparato muscolo-scheletrico in Nefrologia. Milan: Wichtig, 1998; 1-45.
35. Bouret S, De Seranno S, Beauvillain JC, Prevot V. Transforming growth factor β1 may directly influence gonadotropin-releasing hormone gene expression in the rat hypothalamus. Endocrinology 2001; 145: 1794-01.